Urogen Pharma (URGN)

Urogen Pharma (URGN) Financial Statements


Urogen Pharma Financial Overview

Urogen Pharma's market cap is currently ―. The company's EPS TTM is $-4.786; its P/E ratio is -1.83; Urogen Pharma is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 16.10M$ 16.60M$ 13.56M$ 16.17M$ 11.35M
Gross Profit$ 14.08M$ 14.76M$ 12.04M$ 14.59M$ 10.11M
EBIT$ -22.43M$ -24.42M$ -27.79M$ -19.91M$ -23.44M
EBITDA$ -21.99M$ -23.94M$ -27.33M$ -19.46M$ -22.99M
Net Income Common Stockholders$ -25.83M$ -26.69M$ -28.39M$ -28.45M$ -30.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 95.91M$ 111.74M$ 136.44M$ 89.14M$ 106.21M
Total Assets$ 128.47M$ 146.14M$ 165.72M$ 119.75M$ 134.60M
Total Debt$ 73.73M$ 72.71M$ 71.07M$ 398.00K$ 616.00K
Net Debt$ -22.18M$ -39.03M$ -65.37M$ -88.74M$ -105.59M
Total Liabilities$ 191.76M$ 187.05M$ 182.79M$ 111.33M$ 103.07M
Stockholders Equity$ -63.29M$ -40.91M$ -17.07M$ 8.41M$ 31.54M
Cash Flow-
Free Cash Flow$ -17.77M$ -24.26M$ -24.02M$ -20.27M$ -18.67M
Operating Cash Flow$ -17.61M$ -24.20M$ -24.00M$ -20.07M$ -18.48M
Investing Cash Flow$ -35.49M$ -151.00K$ 13.60M$ 9.13M$ 10.66M
Financing Cash Flow$ 1.10M$ -77.00K$ 70.74M$ -32.00K$ -168.00K
Currency in USD

Urogen Pharma Earnings and Revenue History

Urogen Pharma Debt to Assets

Urogen Pharma Cash Flow

Urogen Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis